Hypertension Cost of Illness in the U.S.

Categories
DataInsightsNewsPodcastsRecordingsWebinarsWork
Topics
Behavioral HealthCare Delivery IntegrationCare WorkforceCaregivingcomplex carehealthHealthcare Business StrategyHealthcare EquityHealthcare Financing and Delivery InnovationHealthcare InnovationHospitalsInflation Reduction ActLTSSMedicare AdvantageMedicare and Medicaid Program DesignMedicare-Medicaid IntegrationPharmaceutical InnovationPopulation Health and Person-Centered CareSenior Care and Senior LivingState Resource CenterState Support

Hypertension Drives Billions of Dollars in Avoidable Healthcare and Workforce Productivity Costs

Hypertension Cost of Illness in the U.S.

States, employers, and individuals in every state experience the high economic burden of hypertension.

Hypertension can lead to poor outcomes, including increased risk for heart disease, stroke, dementia, vision loss, and chronic kidney disease. ATI’s first-of-its-kind model estimates the national and state hypertension-attributable medical and labor cost of illness.

Hypertension Cost by State Hypertension by the Numbers Technical Report

Hypertension Costs by State in 2025

ATI’s first-of-its-kind model estimates the hypertension-attributable medical and labor cost of illness by state. Use the map to access information on hypertension costs for individual states and their employers.
View Hypertension Costs Nationally

AL AK AZ AR CA CO CT DE FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY DC

Hypertension is defined as average blood pressure ≥140/90 mmHg, taking medication to control hypertension, or both. Uncontrolled hypertension is defined as average blood pressure ≥140/90 mmHg, regardless of whether the individual is taking prescription medications. Hypertension-attributable costs include medical costs (e.g., physician visits, medication, hospitalizations) and productivity costs (e.g., absenteeism, presenteeism).

ATI created this model and related materials with technical collaboration and funding from AstraZeneca. ATI retained editorial control over the model and methodological decisions.

Hypertension by the Numbers in the U.S.

32%

of adults have hypertension, and 48% of the hypertensive population has uncontrolled hypertension

$292B

is the total cost of hypertension annually

53%

of the cost burden for hypertension among the working-age population falls on employers

$5B

in net annual savings may be achieved by addressing uncontrolled hypertension

AHA, ACC, and 11 other medical societies recommend evidence-based hypertension control strategies, including improved screening, treatment access, and team-based care, to reduce hypertension risks that drive costs and weaken the workforce.

Technical Report

Quantifying the Annual Macroeconomic Impact of Hypertension

Dig deeper into ATI’s analysis of costs attributable to hypertension, allocated by state and payer.

Download the Report